Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Pharmacokinetics of Plerixafor (AMD3100) in Volunteers with Renal Impairment.

Ronald MacFarland, PhD, Reginal B. Ewesuedo, MD, Karin Badel, Gary Calandra, MD

Blood (2007) 110 (11): 2878.

https://doi.org/10.1182/blood.V110.11.2878.2878

Published: 2007

Journal Articles

AMD3100 Plus G-CSF Mobilizes the Majority of Non-Hodgkin’s Lymphoma (NHL), Multiple Myeloma (MM), and Hodgkin’s Disease (HD) Patients Who Failed Prior Mobilization with Other Regimens.

Gary Calandra, John McCarty, Joseph McGuirk, Bart Barlogie, Sue-Anne Crocker, Karin Badel

Blood (2006) 108 (11): 5218.

https://doi.org/10.1182/blood.V108.11.5218.5218

Published: 2006

Journal Articles

Steady State Mobilization of Autologous Blood Stem Cells Using G-CSF and AMD3100 in Patients with Multiple Myeloma (MM).

Gerhard Ehninger, Stefan Fruehauf, Kai Hubel, Uwe Platzbecker, Karin Badel, Gary Calandra

Blood (2006) 108 (11): 5219.

https://doi.org/10.1182/blood.V108.11.5219.5219

Published: 2006

Journal Articles

Single Agent AMD3100 Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation in Patients with Multiple Myeloma (MM).

Neal Flomenberg, MD, Raymond Comenzo, MD, Karin Badel, Gary Calandra, MD

Blood (2006) 108 (11): 3381.

https://doi.org/10.1182/blood.V108.11.3381.3381

Published: 2006

Journal Articles

AMD3100 with G-CSF for Autologous Peripheral Blood Progenitor Cell (PBPC) Mobilization in Non-Hodgkin’s Lymphoma (NHL) and Multiple Myeloma (MM): Mobilization, Engraftment, and Pharmacokinetics (PK).

Stewart Douglas, Clayton Smith, Ron McFarland, Karin Badel, Gary Calandra

Blood (2006) 108 (11): 3383.

https://doi.org/10.1182/blood.V108.11.3383.3383

Published: 2006

Journal Articles

AMD3100 Plus G-CSF Use in Proven Poor Mobilizers in a Compassionate Use Protocol (CUP).

Joseph McGuirk, MD, John McCarty, MD, Kaaren Gibb, BSc, Karin Badel, BSc, N Gary Bridger, PhD, Gary Calandra, PhD, MD

Blood (2005) 106 (11): 154.

https://doi.org/10.1182/blood.V106.11.154.154

Published: 2005

Journal Articles

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone

Neal Flomenberg, Steven M. Devine, John F. DiPersio, Jane L. Liesveld, John M. McCarty, Scott D. Rowley, David H. Vesole, Karin Badel, Gary Calandra

Blood (2005) 106 (5): 1867–1874.

https://doi.org/10.1182/blood-2005-02-0468

Published: 2005

Journal Articles

A Pilot Study Evaluating the Safety and Efficacy of AMD3100 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients with Advanced Hematological Malignancies.

Steven M. Devine, MD, Jesper Bonde, PhD, David A. Hess, PhD, Terri M. Edwards, Daniel C. Link, MD, Diane Sempek, Gary Calandra, MD, Karin Badel, Jan A. Nolta, MD, John F. DiPersio, MD, PhD

Blood (2004) 104 (11): 3341.

https://doi.org/10.1182/blood.V104.11.3341.3341

Published: 2004

Journal Articles

AMD3100 Combined with Standard Doses of G-Csf Leads to Rapid, Consistent Mobilization of Hematopoietic Progenitor Cells in Patients with Non-Hodgkin’s Lymphoma (NHL) and Multiple Myeloma.

Patrick Stiff, MD, Ivana Micallef, MD, Philip McCarthy, MD, Margarida Magalhaes-Silverman, MD, Neal Flomenberg, MD, Daniel Weisdorf, MD, Guido Tricot, MD, Mary Territo, MD, Rafat Abonour, MD, Karin Badel, Gary Calandra, MD/PhD

Blood (2004) 104 (11): 2847.

https://doi.org/10.1182/blood.V104.11.2847.2847

Published: 2004

Journal Articles

Improved Mobilization of CD34+ Peripheral Blood Stem Cells (PBSC) and Dendritic Cells (DCs) by AMD-3100 (AMD) in Hard to Mobilize Non-Hodgkin’s Lymphoma (NHL) Patients (pts) Mobilized with Standard Dose of G-CSF.

Yair Gazitt, Ph.D, Cesar O Freytes, M.D, Cagla Akay, M.D, William Bensinger, M.D, Karin Badel, R.N, Gary Calandra, M.D

Blood (2004) 104 (11): 2856.

https://doi.org/10.1182/blood.V104.11.2856.2856

Published: 2004

Journal Articles

Treatment with AMD3100 in Multiple Myeloma or Non-Hodgkin’s Lymphoma Patients to Increase the Number of Peripheral Blood Stem Cells When Given with a Mobilizing Regimen of Chemotherapy and G-CSF.

Michael J. Dugan, MD, Luke P. Akard, MD, James M. Thompson, DO, Auayporn Nademanee, MD, Richard T. Maziarz, MD, William I. Bensinger, MD, Jane Liesveld, MD, Karin Badel, Christine Dehner, Colleen Gibney, Gary Calandra, Jan Jansen, MD, PhD

Blood (2004) 104 (11): 2860.

https://doi.org/10.1182/blood.V104.11.2860.2860

Published: 2004

NARROW

Pharmacokinetics of Plerixafor (AMD3100) in Volunteers with Renal Impairment.

AMD3100 Plus G-CSF Mobilizes the Majority of Non-Hodgkin’s Lymphoma (NHL), Multiple Myeloma (MM), and Hodgkin’s Disease (HD) Patients Who Failed Prior Mobilization with Other Regimens.

Steady State Mobilization of Autologous Blood Stem Cells Using G-CSF and AMD3100 in Patients with Multiple Myeloma (MM).

Single Agent AMD3100 Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation in Patients with Multiple Myeloma (MM).

AMD3100 with G-CSF for Autologous Peripheral Blood Progenitor Cell (PBPC) Mobilization in Non-Hodgkin’s Lymphoma (NHL) and Multiple Myeloma (MM): Mobilization, Engraftment, and Pharmacokinetics (PK).

AMD3100 Plus G-CSF Use in Proven Poor Mobilizers in a Compassionate Use Protocol (CUP).

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone

A Pilot Study Evaluating the Safety and Efficacy of AMD3100 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients with Advanced Hematological Malignancies.

AMD3100 Combined with Standard Doses of G-Csf Leads to Rapid, Consistent Mobilization of Hematopoietic Progenitor Cells in Patients with Non-Hodgkin’s Lymphoma (NHL) and Multiple Myeloma.

Improved Mobilization of CD34+ Peripheral Blood Stem Cells (PBSC) and Dendritic Cells (DCs) by AMD-3100 (AMD) in Hard to Mobilize Non-Hodgkin’s Lymphoma (NHL) Patients (pts) Mobilized with Standard Dose of G-CSF.

Treatment with AMD3100 in Multiple Myeloma or Non-Hodgkin’s Lymphoma Patients to Increase the Number of Peripheral Blood Stem Cells When Given with a Mobilizing Regimen of Chemotherapy and G-CSF.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only